AVITA’s RECELL System Revenue Rose 161%, Share Price up ~7%

AVITA Therapeutics Inc (ASX:AVH) disclosed its annual report for FY20 (year ended 30 June 2020).

  • Revenue of the RECELL System totaled US$14.3 million for the financial year 2020, an increase of 161% (or US$8.8 million) over the US$5.5 million for FY19.
  • During the period, US sales totaled US$13.8 million compared to US$4.4 million in the prior year.
  • AVITA had cash and restricted cash of US$73.8 million as of 30 June 2020 compared to US$20.4 million as of 30 June 2019.

Post announcement on 28 August 2020, AVH share price was trading at A$6.660 up by 8.293% at AEST 12:03 AM.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK